RWE Powering Its Renewable Future; Tailwinds Mean Increased Earnings In 2020

Keith Williams
8.79K Followers

Summary

  • 2020 guidance on target: EBITDA 2.15-2.45 billion euros, net income 0.85-1.15 billion euros, dividend target 0.85 euro/share.
  • RWE, a major global investor in renewables, especially offshore wind with interests in Europe, the US, and emerging markets in Japan, Taiwan, South Korea.
  • RWE heads the largest hydrogen consortium in Germany, with further hydrogen interests in the Netherlands and the UK.
  • The company exiting fossil fuels: successful tenderer for two large (1,558 MW) hard coal power station closures.
  • RWE is a major German global new energy company with a big focus on offshore wind that is worth considering for new energy investors.

RWE history included looking at electric cars

"We drive with electricity"; early days at RWE. Source RWE

RWE Aktiengesellschaft (OTCPK:RWEOY) has a 120-year history as a major power company in Germany. Its history makes fascinating reading. It is complicated, with lots of twists and turns (including a major role in coal and nuclear power generation ... and even playing with electric cars) and its latest evolution is the result of a huge transaction in Germany with new definition for two major German companies: RWE and E.ON SE (OTCPK:EONGY) (OTCPK:ENAKF).

RWE has taken on the upstream renewable energy assets, while E.ON SE becomes power delivery and customer focused. If one looks for comparisons, RWE now looks like a renewable energy version of one of the oil and gas majors. It has a heavy emphasis on renewable power generation (especially wind) and an international focus. And it has an ambitious goal of neutral emissions by 2040. RWE has share performance that oil and gas majors would die for, being up 36% year on year. E.ON SE has a more modest share price performance, although it has survived 2020 with a 3% increase in share price year on year, after a dramatic fall at the start of the pandemic. Here I look at RWE's Q3 results to provide further information about investment in interesting renewable energy companies, flowing on from my comparison of Vestas Wind Systems (OTCPK:VWDRY) and Exxon Mobil (XOM).

If you are looking to internationalise your energy investment portfolio with a strong focus on offshore wind, RWE should be on your radar.

RWE used to be heavily focused on large base-load power generation with a core of coal and nuclear power assets. Government decisions in Germany foreshadowed the end of both of these industries some time ago, so it has had to reinvent itself and it did so by heavily

This article was written by

8.79K Followers
Keith began his career as a research scientist (developmental biology, biochemistry, molecular biology) at the Australian National University, University of Oxford (UK), the Max Planck Institute for Biochemistry (Munich, Germany) and finally Macquarie University (Sydney) where he held a Chair in Biology and established the Centre for Analytical Biotechnology. Pioneering the area of proteomics (with Marc Wilkins in his group coining the term), Keith established the world’s first government-funded Major National Proteomics Facility (Australian Proteome Analysis Facility) which was involved with industrialising protein science. Keith left academe with his team to found Proteome Systems Ltd in 1999 to commercialise proteomics. The company had a strong focus on intellectual property, engineering/technology and bioinformatics. As CEO he led the company to ASX listing in 2004. Since 2005 Keith has been involved in new business development in biotech, e-health and other emerging technologies. Keith sees climate change and sustainable development as a major issue for humankind and also a major business disruptor/risk and opportunity. Keith holds a Bachelor Agr Science from the University of Melbourne and a PhD from the Australian National University. He is a Fellow of the Australian Academy of Technological Sciences & Engineering and received an AM (Member of the Order of Australia) for services to the Biotechnology Industry. He has received various industry awards including an Innovation Hero Medal from the Warren Centre for Advanced Engineering. With 300 scientific papers and many patents written, Keith has a clear view of innovation in the Biotechnology and Climate/Renewable Energy space. He is not a financial advisor but his perspective adds relevance to decision-making concerning feasibility and investment in technology innovation.

Analyst’s Disclosure:I am/we are long VWDRY. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I may initiate a long position in RWEOY over the next 72 hours

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About RWEOY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on RWEOY

Related Stocks

SymbolLast Price% Chg
RWEOY
--
RWNEF
--